Loading…
Based on limited metadata, this warning letter was issued to Hangzhou Linkeweier Daily Chemicals Co., Ltd., a pharmaceutical manufacturer, on March 13, 2020. Without access to the full letter text or subject line details, the specific violations cannot be determined from the available information. The FDA's regulatory scope covered drug products manufactured by this company, though the issuing office location is not specified in the metadata provided.